Abstract
Carotid artery stenosis (CAS) is among the leading causes of mortality and permanent disabilities in the Western world. CAS is a consequence of systemic atherosclerotic disease affecting the majority of the aging population. Optical coherence tomography angiography (OCTA) is a novel imaging technique for visualizing retinal blood flow. It is a noninvasive, fast method for qualitative and quantitative assessment of the microcirculation. Cerebral and retinal circulation share similar anatomy, physiology, and embryology; thus, retinal microvasculature provides a unique opportunity to study the pathogenesis of cerebral small vessel disease in vivo. In this study, we aimed to analyze the effect of systemic risk factors on retinal blood flow in the eyes of patients with significant carotid artery stenosis using OCT angiography. A total of 112 eyes of 56 patients with significant carotid stenosis were included in the study. We found that several systemic factors, such as decreased estimated glomerular filtration rate (eGFR), hypertension, and carotid occlusion have a significant negative effect on retinal blood flow, while statin use and carotid surgery substantially improve ocular microcirculation. Neither diabetes, clopidogrel or acetylsalicylic acid use, BMI, serum lipid level, nor thrombocyte count showed a significant effect on ocular blood flow. Our results demonstrate that a systematic connection does exist between certain systemic risk factors and retinal blood flow in this patient population. OCTA could help in the assessment of cerebral circulation of patients with CAS due to its ability to detect subtle changes in retinal microcirculation that is considered to represent changes in intracranial blood flow.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Avoid common mistakes on your manuscript.
Introduction
Carotid artery stenosis (CAS) is among the most important health concerns as it frequently leads to transient ischemic attacks (TIA) or ischemic stroke—these being one of the leading causes of mortality and permanent disabilities [1, 2]. The principal risk factors for carotid artery disease are being aged over 50, hyperlipidemia, smoking, coronary disease, peripheral artery disease, stroke, or TIA in the patient’s medical history, or the occurrence of a cardiovascular event in family members younger than 60 years [3]. Treatment can be through conservative or surgical therapy. Conservative therapy is recommended in asymptomatic cases when the extent of the stenosis is lower than 70% or when the risk of an intervention is too high compared to its potential benefits. If surgery is required, endarterectomy is the preferred treatment option due to the lower perioperative stroke rate [4, 5].
The preferred diagnostic method for CAS in current practice is Duplex ultrasound, which provides morphological information and allows one to quantify the extent of the stenosis. Although it can be a reliable examination method if performed by a trained examiner, several human factors can result in an increase of variability and error during ultrasound examinations [6, 7]. CT or MR angiography are more objective methods that are mostly used in reconstruction planning.
Through thromboembolic and hemodynamic mechanisms, CAS can also lead to severe ophthalmic complications, which are often a predictor for the occurrence of cerebrovascular accidents. Transient monocular visual loss (amaurosis fugax) is caused by a temporary decrease in blood flow and usually lasts from seconds to minutes, though in rare cases, can persist for hours [8]. The most common cause is embolization from the ipsilateral carotid artery resulting in the ischemia of the retina, the choroid, or the optic nerve; that said, hypotension or vasospasm can also lead to hypoperfusion [9]. Embolization can also lead to sudden, painless, but permanent blindness due to a retinal stroke [10].
The examination of ophthalmic complications of CAS is conventionally possible by slit-lamp examination and funduscopy. Optical coherence tomography angiography is a new method for visualizing and analyzing the retinal and choroidal vasculature without the use of intravenous dye [11]. With the use of OCT angiography, subtle changes in retinal blood flow can be detected, with high accuracy. Owing to the short acquisition time, and since it is noninvasive, OCTA is beneficial to patient comfort and can be repeated at any time during follow-up visits. Numerous studies have described the high accuracy and reproducibility of OCTA parameters in normal subjects [12,13,14,15,16,17,18,19], as well as in patients with diabetes [20], glaucoma [21], ischemic optic neuropathy, [22] and retinal vascular diseases [23, 24]. However, it is known, that image quality significantly affects both the measurement error [25,26,27,28,29] alongside the OCTA parameters [30] suggesting the need to use a correction factor for longitudinal analysis.
In a recent study, Lahme et al. described reduced retinal flow density in CAS patients compared to healthy controls, and a significant improvement in the capillary network was also noted after surgery using OCTA [31]. Furthermore, Lee et al. found a significant increase in the vessel density of the macular deep vessel complex on both eyes after surgical procedure for CAS [32]. Although these studies reported an improvement in retinal blood flow after carotid endarterectomy, none of them took into consideration the effect of systemic risk factors or image quality on retinal blood flow measurements.
The purpose of this study was to analyze the effect of systemic risk factors on retinal blood flow in eyes of patients with significant carotid artery stenosis using OCT angiography before and after carotid surgery.
Methods
In this prospective clinical study, a total of 56 patients with significant carotid artery stenosis were enrolled, all of them prepared to undergo carotid endarterectomy at the Department of Vascular & Endovascular Surgery at Semmelweis University. The study followed the tenets of the Declaration of Helsinki’s applicable national and local requirements and was approved prospectively by the Ethical Review Board for Human Research of the National Drug Agency. All participants gave their written informed consent.
Inclusion criteria for the study were twofold: significant carotid artery stenosis (≥ 70%) and planned endarterectomy. Exclusion criteria were associated with ocular disease (such as age-related macular degeneration, glaucoma, or vitreomacular disease), previous intraocular anti-VEGF injection, and the presence of clinically significant media opacities.
The severity of carotid artery stenosis was assessed by computed tomography angiography (CTA) as part of the clinical routine. All carotid patients underwent preoperative, unenhanced cranial 256-slice scanner CT. CTA of the carotid arteries was performed from the level of the aortic arch to the vertex using bolus tracking (Brilliance iCT 256, Philips Healthcare, Best, The Netherlands). The following imaging parameters were used for data acquisition: 120 kV, 50–160 mAs/slice, slice thickness 0.67 mm, Philips® IMR reconstruction, an intravenous contrast agent (Iomeron400), 50 ml at a flow rate of 5 ml/sec.
Definitions of patient characteristics
Several separate patient characteristics were measured—specifically carotid artery stenosis, hypertension, diabetes, patients’ treatment, chronic kidney disease, eGFR—as follows: unequivocal diagnosis of significant carotid artery stenosis and the indication for reconstruction was determined through CT angiography based on the NASCET criteria [33]. Hypertension was defined according to the 2020 American Heart Association (AHA) guidelines [34], while diabetes was defined in line with the 2019 ESC guideline [35], and the patients’ treatment was described by their general practitioner before the procedures. Chronic kidney disease (CKD) was defined as the preoperative estimated glomerular filtration rate (eGFR; ml/min/1.73m2) < 60 according to the Kidney Disease: Improving Global Outcomes (KDIGO)[36]. The eGFR was calculated with reference to an average person with a body surface of 1.73 m2 and was not corrected for gender or body mass index (BMI). The best medical therapy was administered for all patients after the result of the CT angiography (Aspirin 100 mg once or Clopidogrel 75 mg once with a statin) according to the European Society for Vascular Surgery (ESVS) guidelines [37].
Surgical procedure
Surgical treatment was performed at Semmelweis University Department of Vascular & Endovascular Surgery. All patients underwent carotid artery reconstruction under general anesthesia. The incision made was longitudinal, parallel to the medial border of the sternocleidomastoid muscle, the carotid sheath being entered, and the medial border of the jugular vein dissected. Most of the patients underwent eversion endarterectomy, which was performed with the complete transection of the bifurcation; followed by everting the adventitia and mobilizing it upward while gentle caudad traction was applied to the plaque. After the endarterectomy, the divided bifurcation was reunited with a simple end-to-end anastomosis. The patients who were selected for shunting with Pruitt–Inawera shunt, underwent a conventional endarterectomy, which consists of a vertical arteriotomy from CCA (common carotid artery) to ICA (internal carotid artery) and closure using bovine patch angioplasty. The shunting was indicated preoperatively based on the Circle of Willis (CoW) status. Near-infrared spectroscopy (NIRS) was used for cerebral monitoring.
Optical coherence tomography angiography
Each study subject underwent three sessions of imaging, during which three OCTA images of the macular area and three images of the optic nerve head were obtained consecutively. The first session was scheduled during the perioperative period, the other two during the first postoperative week and one month following surgery. Ophthalmologic visits consisted of testing visual acuity, with slit lamp and fundus examinations followed by optical coherence tomography angiography imaging. Optical coherence tomography angiography imaging was performed under the same conditions by a trained examiner. OCTA imaging was performed using an AngioVue device with an SSADA (split-spectrum amplitude-decorrelation angiography) software algorithm (RTVue XR Avanti with AngioVue, Optovue Inc, Fremont, CA, USA). The device obtains 70,000 A-scans per second in approximately 3.0 s. Imaging of the macula required a 3 × 3-mm scan as the current version of AngioAnalytics software acquires scans with the highest resolution in the central 3-mm diameter. Images with movement artifacts (such as vessel doubling, white line artifacts, vessel discontinuities, or noise), projection artifacts, and segmentation errors were excluded. Scan quality (SQ) was required to be above SQ 5, images with an SQ of 5 or below were also excluded. An example of macular vessel density in both eyes of a patient with significant left carotid stenosis is demonstrated in Fig. 1.
Color-coded images of macular vessel density (VD) from both eyes of a patient with left unilateral carotid artery stenosis show preserved retinal blood flow (VD: 44.7%) on the contralateral right eye (a) and areas of non-perfusion (arrows) and decreased overall perfusion (VD:41.9%) in the ipsilateral left eye (b)
Statistical analysis
Statistical analysis was performed with SPSS software (version 23.0, IBM, Armonk, NY, USA). The effect of systemic parameters, as well as image quality on OCTA parameters, was assessed with multivariable regression analysis using generalized estimating equation (GEE) models. In addition to treating repeated measurements (intrasession and between visits), this test enables adjustments to be made for within-subject correlation of parameters (right vs. left eye) by taking into account between-eye correlations. Moreover, the inclusion of scan quality and risk factors as covariates into GEE models permits one to simultaneously control for their effect on the dependent variables. Covariates evaluated as potential confounders included age, degree of stenosis in %, aspirin, clopidogrel, and statin use, BMI, eGFR, and serum cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride level, in addition to the presence of hypertension and diabetes. The effect of systemic predictors on OCTA parameters was analyzed first in bivariable models (adjusting for scan quality for each predictor) and statistically significant predictors entered in multivariable models. The construction of the multivariable regression model began with variables that showed the best fit to data in bivariable modeling—assessed using the value of the corrected quasi-likelihood under independence model criterion (QICC); where lower QICC values indicate a better fit to data. Following this, variables were added and the change in the QICC value was tested. Variables were kept in the model if they were associated with a p value less than 0.01 and the overall fit of the model improved, as indicated by a decrease in the QICC value compared with the value in a model that did not include the variable.
Results
A total of 112 eyes of 56 patients (26 male and 30 female, mean age: 69.89 ± 7.07 years) were included in the study, the baseline characteristics of the study group are summarized in Table 1.
The values of SQ ranged from 6 to 10, the overall mean SQ was (7.45 ± 1.01), and there was no statistically significant difference between the SQ values of the ipsilateral and contralateral side (7.49 ± 0.99 vs. 7.41 ± 1.01; p = 0.12). Scan quality was found to be a significant predictor of superficial capillary vessel density (2.52%; 95%CI: 2.33–2.73%; p < 0.001); thus, scan quality values associated with each measurement were included as confounders in all statistical calculations.
On the eyes ipsilateral to the stenosis, morphological abnormalities—such as capillary dropout areas or deformation and enlargement of the foveal avascular zone (FAZ)—were visible on most of the angiograms. Figure 1 demonstrates mottled areas of capillary loss on the affected side of a patient with unilateral carotid artery stenosis. Although the AngioAnalytics software does not provide any quantitative information about the size of patchy capillary dropout, its summarized impact on macular capillary blood flow is represented in the overall vascular density value.
Subsequently, we evaluated the effect of age, degree of stenosis in %, aspirin, clopidogrel and statin use, BMI, eGFR, serum cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride level, and the presence of hypertension and diabetes. Table 2 summarizes significant predictors of macular vessel density, both in bivariable models and in multivariable regression models. In bivariable regression models (adjusting for the effect of scan quality for each predictor separately), the presence of hypertension showed the greatest effect on vessel density (− 1.56%) followed by statin use (+ 0.95%), carotid surgery (+ 0.54%), higher eGFR (0.34% for 10 units), and carotid stenosis (− 0.11% for 10% stenosis). Age, aspirin and clopidogrel use, BMI, serum cholesterol, LDL, HDL, and triglyceride level or diabetes did not prove to be significant predictors of macular vessel density (p > 0.05). All significant predictors in bivariable models also remained significant predictors of vessel density in the final multivariable model (Table 2). Interestingly, statin use showed a marked positive influence on retinal blood flow, after controlling for the negative effect of hypertension, carotid occlusion, and lower eGFR in these patients both before and after carotid surgery (Table 2). At the first postoperative visit, we observed a significant increase in macular vessel density from baseline values in both the ipsi- and the contralateral eyes with no further improvement until the last measurement is taken 1 month after the intervention. There was no significant difference in the increase of vessel density between the two eyes of the same patient across the postoperative time points. The relative effect of significant predictors on retinal blood flow is summarized in Fig. 2.
Discussion
In the current study, we analyzed the qualitative and quantitative changes in the retinal circulation of patients with severe carotid artery stenosis. We found that several systemic factors, such as decreased eGFR, hypertension, and carotid occlusion have a significant negative effect on retinal blood flow, while statin use and carotid surgery substantially improve ocular blood flow. Confirming previous results, image quality had a statistically significant impact on vessel density and should be taken into consideration in analyzing retinal blood flow using OCT angiography. We found that carotid surgery resulted in a significant improvement in retinal blood flow both ipsi- and contralaterally, independently of systemic factors. It is interesting that in this patient group neither diabetes, clopidogrel or acetylsalicylic acid use, BMI, serum lipid level, nor thrombocyte count showed a significant effect on ocular blood flow. One explanation for this observation is that the strength of association between these risk factors and retinal blood flow decreases with simultaneous analysis of strong predictors, such as hypertension, statin use, or carotid surgery.
Hypertension affects the microcirculation by causing structural changes of the microvasculature through two mechanisms: remodeling of resistance vessels and causing capillary rarefaction [38]. Despite the underlying molecular mechanisms not being fully understood yet, studies suggest that prolonged vasoconstriction, reactive oxygen species (ROS), nitric oxide, matrix metalloproteinases (MMP), and tissue type transglutaminase (TG2) all play a role—leading to the remodeling of the arterioles through activation of cytoskeletal and extracellular matrix structures of the vessel wall [39]. Capillary rarefaction, with the loss of terminal arterioles and capillaries, is also highly associated with the presence of hypertension [40]. It is believed that an imbalance between increased vascular destruction and insufficient angiogenesis leads to its development [33, 41,42,43,44,45]. What is more, these changes have been observed in the cerebral circulation. The first study to report the changes in cerebral blood flow in patients with essential hypertension found higher limits in the cerebral blood flow autoregulation compared to a normotensive control group [46]. Since which, numerous other study groups have revealed alterations in the lumen diameter and the vessel number in the cerebral circulation [47,48,49]. Several studies reported microvascular changes of the retina associated with chronic hypertension. Greater intercapillary distance, reduced capillary area, and reduced retinal capillary flow were detected with the use of Doppler flowmetry [50, 51]. OCTA is also used in the examination of hypertensive patients. Decreased vessel density values were found in both the superficial and deep layers of the retinal capillary plexus; furthermore, the foveal avascular zone was found to have increased both in size and its perimeter compared to a normotensive control group [52, 53]. However, none of those studies controlled for the effect of scan quality on retinal blood flow measurements. It has to be emphasized that disregarding the relationship between OCTA scan quality and retinal vessel density could lead to erroneous conclusions being drawn from detected differences when comparing two study groups or when measuring fluctuations in retinal blood flow during consecutive measurements in these patients.
A correlation between lower eGFR values and impaired cerebral blood flow was previously reported in a population-based study [54]. Others have found an association between kidney function and subclinical markers of cerebral small vessel disease by evaluating MRI scans [55]. Previously, Zhouang et al. found decreased vessel density values in the superficial vascular complex correlated with decreased eGFR in diabetic patients using OCT angiography [56], but this is the first study that describes the significant association between eGFR and retinal blood flow in patients with CAS. The results of this study demonstrate that there is a strong correlation between generalized microvascular problems and renal function, although it is still a point of contention whether microcirculatory changes are a cause or the effect of decreased kidney function. Several studies have described a connection between coronary microvascular dysfunction and kidney disease [57,58,59,60,61]. Notably, Castro et al. found a correlation between impaired cerebral autoregulation and decreased kidney function in patients with acute ischemic stroke [62].
In the current study, we found a beneficial effect of statin use on retinal blood flow. HMG-CoA (3-hydroxy3-methylglutaryl coenzyme A) reductase inhibitors or statins are considered to be a first-line treatment in most cases of CAS as they have been proven to slow down, or may even partially reverse, atherosclerosis. They also appear to improve peripheral endothelial function and decrease carotid intima-media thickness [63]. In addition to lowering LDL-cholesterol levels, statins also have an anti-inflammatory effect, inhibit cell proliferation, promote apoptosis, and have an anticoagulant and antithrombotic effect [64]. Although there are still scant data concerning the effect of cholesterol-lowering therapy on peripheral microvasculature, some studies have confirmed that they are beneficial in regards to improving microcirculation [65, 66]. In animal models, statins were found to increase cerebral blood flow through nitric oxide (NO)-dependent and NO-independent mechanisms [67,68,69]. On the other hand, in human studies, the protective effect of statins was found to be related more to vasoreactivity than to improving cerebral blood flow [70,71,72]. What is more, a recent study found a connection between statin administration and the improvement of capillary rarefaction and microcirculation [73, 74]. As our results demonstrate, OCTA can be a great help in collecting further information with respect to the changes of microcirculation in connection with statin administration and in possibly verifying these previous findings.
There are several direct and indirect methods for assessing cerebral blood flow, though they all have their limitations. Of the direct methods, the most important are single-photon emission computed tomography (SPECT), positron emission tomography (PET), MRI with contrast agents, and arterial spin labeling (ASL) MRI [75]. The majority of these are based on measuring the amount of a tracer is delivered to brain tissue. As such, these are invasive examination methods which are difficult to implement and require complex, expensive equipment. ASL is based on the detection of magnetically labeled water molecules in arterial blood and is a promising new, noninvasive method for measuring intracranial blood flow. The most commonly used indirect methods are transcranial Doppler (TCD) ultrasound imaging, near-infrared spectroscopy (NIRS), and phase-contrast MRI. TCD is a noninvasive examination method during which the flow velocities in the major cerebral arteries are measured through the thinner areas of the skull using an ultrasound probe. The main limitations to TCD are that the accuracy of the measurements is highly operator-dependent and some patients are unsuitable due to inadequate acoustic windows [76]. NIRS is based on the absorption of near-infrared light and exploits the different optical properties of oxygenated and deoxygenated hemoglobin, thus the measurement depends on changes in both the blood flow and oxygen metabolism [76] Phase-contrasting MRI is an accurate and easily reproducible procedure, however, it is only suitable in the assessment of mean overall blood flow [77]. It is important to note that the indirect methods have the disadvantage of being unable to provide information on the flow of arterial blood to the capillary beds.
Being part of the central nervous system, the retina offers a unique and easy method to study cerebral small vessel diseases in vivo. Over the past few decades, a number of novel approaches in retinal imaging have been developed that may allow physicians and researchers to gain insights into the genesis and progression of cerebrovascular pathologies. Previously, apart from knowing the medical history, conventional examination methods helped the diagnostics of ocular complications of vascular diseases such as slit-lamp examination, funduscopy, and fluorescein angiography, which is an invasive technology for visualizing the retinal vasculature [78]. Optical coherence tomography (OCT) helps in visualizing the retinal structures by using low coherence interferometry [79]. High-resolution cross-sectional images can be obtained of the retina which allows in vivo visualization of the different retinal layers. OCT angiography is a fast and noninvasive procedure and is suitable for follow-up of conditions affecting the retinal blood flow. The imaging technique is based on motion contrast technology to detect retinal blood flow. It also enables quantitative measurement of the blood flow in the area of the macula and the optic nerve head, in addition to accurate visualization of microvascular abnormalities and capillary dropout areas in retinal vascular diseases. The software calculates a signal quality score for every scan, based on the signal intensity of the image acquired by the device using different ranges and recommended thresholds provided by the manufacturer. Numerous factors affect the scan quality including media opacities, blink artifacts, ocular saccades, and OCT operator skills. The Scan Quality index is a unitless parameter in the range of 0 to 10 (the larger the better) produced by the RTVue-XR AngioVue software with errors coming from eye motion, defocus, and signal-to-noise ratio incorporated in its formulation. Since image quality significantly affects OCTA parameters, this value has to be taken into consideration during the comparison of OCTA images for reliable results.
The use of OCT angiography—a new, noninvasive, and easily repeatable imaging technique—gives us an opportunity to detect early signs of retinal microvascular abnormalities, which could well mirror changes in the intracranial blood flow. Some previous studies have examined the changes in ophthalmological parameters in patients with CAS in which both morphological and functional changes were found compared to healthy control groups or between the two eyes of patients with unilateral CAS. Havelius et al. compared dark adaptation levels of patients with unilateral CAS to a healthy control group and found that dark adaptation levels were significantly lower in the patient group but found no difference between the two eyes [80]. In another study, functional changes were assessed together with blood flow alterations. Ocular pneumoplethysmography was performed in order to evaluate ophthalmic artery systolic pressure and retinal function was tested through multifocal electroretinography (mfERG) in patients with unilateral stenosis and no manifest ocular complication. They found significantly delayed and reduced electroretinographic responses in the ipsilateral eye. Furthermore, a correlation was observed between the mfERG results and the arterial blood pressure [81]. Sayin et al. evaluated spectral domain optical coherence tomography (SD-OCT) scans of patients with CAS and found a significant decrease in choroidal thickness compared to healthy controls. In the same study, the retinal nerve fiber layer (RNFL) thickness and macular and ganglion cell complex (GCC) thickness were evaluated, with no significant difference being found between the two study groups [82]. Wang et al. observed a correlation between the thinning of the RNFL layer and the presence of asymptomatic carotid artery stenosis by evaluating SD-OCT measurements of each patient [83]. Another study detected a thinning of the average RNFL thickness and macular thickness (MT) in the nine Early Treatment Diabetic Retinopathy Study (ETDRS) areas compared to a healthy control group [84]. In contrast, Heßler et al. assessed the different morphological and functional changes in the retina (such as RNFL thickness, total macular volume, optic nerve head volume, and visual acuity) and found no changes compared to a control group [85]. Other study groups examined the effect of carotid endarterectomy on ocular parameters. Yan et al. studied both subjective and objective visual functions—such as visual acuity, visually evoked potential, electroretinographic parameters, static, and kinetic visual field—and found a significant improvement in them [86]. Although they found no change in RNFL thickness, others could detect a significant decrease in peripapillary RNFL thickness after surgery [87]. Another study described a significant increase in choroidal thickness in patients with a 50–70% stenosis evaluating enhanced depth imaging optical coherence tomography (EDI-OCT) images [88].
In a recent study, Lahme et al. measured retinal flow density values in OCTA images and described a reduced flow density in CAS patients compared to healthy controls, and they did not find any difference between the ipsilateral and the contralateral eye. A significant improvement in the radial peripapillary capillary network (RPC) was also noted but no significant change was seen in superficial or deep layers of the macular area [31]. Lee et al. also performed OCTA examinations and evaluated the changes in retinal microcirculation before and after surgical procedure for CAS and found a significant increase in the vessel density of the macular deep vessel complex on both eyes. On the contralateral eye, the vessel density also improved in the superficial layer [32]. That said, in addition to having taken no notice of the effect of image quality on OCTA parameters, no previous study has evaluated the effect of systemic factors on retinal blood flow data from the two eyes of the same subject.
One of the limitations of this study is that the acquired data was obtained using a specific type of device restricting the generalizability of our results. However, the findings clearly show that a systematic connection does exist between certain systemic risk factors and retinal blood flow in this patient population. Further studies with larger cohorts of patients are recommended to validate these associations and to assess their relation to intracranial blood flow. Finally, whereas image quality-adjusted OCTA values are associated with improved comparability of scans, it needs to be confirmed whether the detection of changes in retinal microcirculation could help in the assessment of intracranial blood flow in patients with carotid occlusion. Nevertheless, any advancement that improves the ability to detect true changes in intracranial blood flow over time is valuable, and future studies could help to assess the role of OCTA metrics in the clinical setting. We are of the opinion that the implementation of OCTA imaging in the diagnostic armamentarium may well result in increased accuracy of the assessment of progression and treatment of these patients.
References
Flaherty ML, Kissela B, Khoury JC, Alwell K, Moomaw CJ, Woo D, Khatri P, Ferioli S, Adeoye O, Broderick JP, Kleindorfer D. Carotid artery stenosis as a cause of stroke. Neuroepidemiology. 2013;40(1):36–41.
Ay H, Arsava EM, Andsberg G, Benner T, Brown RD Jr, Chapman SN, Cole JW, Delavaran H, Dichgans M, Engström G, Giralt-Steinhauer E, Grewal RP, Gwinn K, Jern C, Jimenez-Conde J, Jood K, Katsnelson M, Kissela B, Kittner SJ, Kleindorfer DO, Labovitz DL, Lanfranconi S, Lee JM, Lehm M, Lemmens R, Levi C, Li L, Lindgren A, Markus HS, McArdle PF, Melander O, Norrving B, Peddareddygari LR, Pedersén A, Pera J, Rannikmäe K, Rexrode KM, Rhodes D, Rich SS, Roquer J, Rosand J, Rothwell PM, Rundek T, Sacco RL, Schmidt R, Schürks M, Seiler S, Sharma P, Slowik A, Sudlow C, Thijs V, Woodfield R, Worrall BB, Meschia JF. Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network. Stroke. 2014;45(12):3589–96.
Mathiesen EB, Joakimsen O, Bønaa KH. Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø Study. Cerebrovasc Dis. 2001;12(1):44–51.
Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. Jul 2010;363(1):11–23.
Hill MD, Brooks W, Mackey A, Clark WM, Meschia JF, Morrish WF, Mohr JP, Rhodes JD, Popma JJ, Lal BK, Longbottom ME, Voeks JH, Howard G, Brott TG; CREST Investigators. Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation. Dec 2012;126(25):3054–61.
Lui EY, Steinman AH, Cobbold RS, Johnston KW. Human factors as a source of error in peak Doppler velocity measurement. J Vasc Surg. 2005;42(5):972–9.
Logason K, Bärlin T, Jonsson ML, Boström A, Hårdemark HG, Karacagil S. The importance of Doppler angle of insonation on differentiation between 50–69% and 70–99% carotid artery stenosis. Eur J Vasc Endovasc Surg. 2001;21(4):311–3.
Kvickström P, Lindblom B, Bergström G, Zetterberg M. Amaurosis fugax: risk factors and prevalence of significant carotid stenosis. Clin Ophthalmol. 2016;10:2165–70.
Biousse V, Trobe JD. Transient monocular visual loss. Am J Ophthalmol. 2005;140(4):717–21.
Lawrence PF, Oderich GS. Ophthalmologic findings as predictors of carotid artery disease. Vasc Endovascular Surg. 2002 Nov-Dec 2002;36(6):415–24.
Spaide RF, Klancnik JM, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50.
Coscas F, Sellam A, Glacet-Bernard A, Jung C, Goudot M, Miere A, Souied EH. Normative data for vascular density in superficial and deep capillary plexuses of healthy adults assessed by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57:211–23.
Shiihara H, Sakamoto T, Yamashita T, Kakiuchi N, Otsuka H, Terasaki H, Sonoda S. Reproducibility and differences in area of foveal avascular zone measured by three different optical coherence tomographic angiography instruments. Sci Rep. 2017;7:9853.
Guo J, She X, Liu X, Sun X. Repeatability and Reproducibility of foveal avascular zone area measurements using AngioPlex spectral domain optical coherence tomography angiography in healthy subjects. Ophthalmologica. 2017;237:21–8.
Lei J, Durbin MK, Shi Y, Uji A, Balasubramanian S, Baghdasaryan E, Al-Sheikh M, Sadda SR. Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images. JAMA Ophthalmol. 2017;135:1092–8.
Al-Sheikh M, Tepelus TC, Nazikyan T, Sadda SR. Repeatability of automated vessel density measurements using optical coherence tomography angiography. Br J Ophthalmol. 2017;101:449–52.
Venugopal JP, Rao HL, Weinreb RN, Pradhan ZS, Dasari S, Riyazuddin M, Puttiah NK, Rao DAS, Devi S, Mansouri K, Webers CA. Repeatability of vessel density measurements of optical coherence tomography angiography in normal and glaucoma eyes. Br J Ophthalmol. 2018;102:352–7.
Fenner BJ, Tan GSW, Tan ACS, Yeo IYS, Wong TY, Cheung GCM. Identification of imaging features that determine quality and repeatability of retinal capillary plexus density measurements in OCT angiography. Br J Ophthalmol. 2018;102:509–14.
Odabaş Ö, Demirel S, Özmert E, Batioğlu F. Repeatability of automated vessel density and superficial and deep foveal avascular zone area measurements using optical coherence tomography angiography: Diurnal Findings. Retina. 2018;38:1238–45.
Czakó C, Sándor G, Ecsedy M, Récsán Z, Horváth H, Szepessy Z, Nagy ZZ, Kovács I. Intrasession and between-visit variability of retinal vessel density values measured with OCT angiography in diabetic patients. Sci Rep. 2018;8:10598.
Van Melkebeke L, Barbosa-Breda J, Huygens M, Stalmans I. Optical coherence tomography angiography in glaucoma: a review. Ophthalmic Res. 2018;60:139–51.
Sharma S, Ang M, Najjar RP, Sng C, Cheung CY, Rukmini AV, Schmetterer L, Milea D. Optical coherence tomography angiography in acute non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2017;101:1045–51.
Lee M, Kim KM, Lim HB, Jo YJ, Kim JY. Repeatability of vessel density measurements using optical coherence tomography angiography in retinal diseases. Br J Ophthalmol. 2019;103:704–10.
O’Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018;136:1242–8.
Czakó C, István L, Ecsedy M, Récsán Z, Sándor G, Benyó F, Horváth H, Papp A, Resch M, Borbándy Á, Nagy ZZ. Kovács I The effect of image quality on the reliability of OCT angiography measurements in patients with diabetes. Int J Retina Vitreous. 2019;5:46.
Yu JJ, Camino A, Liu L, Zhang X, Wang J, Gao SS, Jia Y, Huang D. Signal Strength Reduction Effects in OCT Angiography. Ophthalmol Retina. 10 2019;3(10):835–842.
Yu S, Frueh BE, Steinmair D, Ebneter A, Wolf S, Zinkernagel MS, Munk MR. Cataract significantly influences quantitative measurements on swept-source optical coherence tomography angiography imaging. PLoS One. 2018;13(10):e0204501.
Al-Sheikh M, Ghasemi Falavarjani K, Akil H, Sadda SR. Impact of image quality on OCT angiography based quantitative measurements. Int J Retina Vitreous. 2017;3:13.
Holló G. Influence of posterior subcapsular cataract on structural OCT and OCT angiography vessel density measurements in the peripapillary retina. J Glaucoma. 04 2019;28(4):e61-e63.
Czakó C, István L, Benyó F, Élő Á, Erdei G, Horváth H, Nagy ZZ, Kovács I. The impact of deterministic signal loss on OCT angiography measurements. Transl Vis Sci Technol. 2020;9(5):10.
Lahme L, Marchiori E, Panuccio G, Nelis P, Schubert F, Mihailovic N, Torsello G, Eter N, Alnawaiseh M. Changes in retinal flow density measured by optical coherence tomography angiography in patients with carotid artery stenosis after carotid endarterectomy. Sci Rep. 11 2018;8(1):17161.
Lee CW, Cheng HC, Chang FC, Wang AG. Optical coherence tomography angiography evaluation of retinal microvasculature before and after carotid angioplasty and stenting. Sci Rep. 10 2019;9(1):14755.
North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Hachinski VC, Wiebers DO, Eliasziw M. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 Aug 15;325(7):445–53.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020 Jan 7;41(2):255–323. Erratum in: Eur Heart J. 2020 Dec 1;41(45):4317.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013; 3: 1–150.
Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, Hamilton G, Kakisis J, Kakkos S, Lepidi S, Markus HS, McCabe DJ, Roy J, Sillesen H, van den Berg JC, Vermassen F, Esvs Guidelines Committee, Kolh P, Chakfe N, Hinchliffe RJ, Koncar I, Lindholt JS, Vega de Ceniga M, Verzini F, Esvs Guideline Reviewers, Archie J, Bellmunt S, Chaudhuri A, Koelemay M, Lindahl AK, Padberg F, Venermo M. Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical practice guidelines of the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Jan;55(1):3–81.
Feihl F, Liaudet L, Waeber B. The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep. 2009;11(3):182–9.
Castorena-Gonzalez JA, Staiculescu MC, Foote C, Martinez-Lemus LA. Mechanisms of the inward remodeling process in resistance vessels: is the actin cytoskeleton involved? Microcirculation. 2014;21(3):219–29.
Rudemann AD. Conjunctival vessels. JAMA. 1933;101(19):1477–81.
Serné EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension. 2001;38:238–42.
Serné EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33:998–1001.
Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99:1873–9.
Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999;34:655–8.
Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart. 2003;89:175–8.
Sokolova IA, Manukhina EB, Blinkov SM, Koshelev VB, Pinelis VG, Rodionov IM. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. Microvasc Res. 1985;30(1):1–9.
Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13(6 Pt 2):968–72.
Dunn WR, Wallis SJ, Gardiner SM. Remodelling and enhanced myogenic tone in cerebral resistance arteries isolated from genetically hypertensive Brattleboro rats. J Vasc Res. 1998 Jan-Feb;35(1):18–26.
Baumbach GL, Dobrin PB, Hart MN, Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res. 1988;62(1):56–64.
Jumar A, Harazny JM, Ott C, Kistner I, Friedrich S, Schmieder RE. Improvement in retinal capillary rarefaction after Valsartan treatment in hypertensive patients. J Clin Hypertens (Greenwich). 11 2016;18(11):1112–1118.
Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE. Retinal capillary rarefaction in patients with untreated mild-moderate hypertension. BMC Cardiovasc Disord. 2017;17(1):300.
Sun C, Ladores C, Hong J, Nguyen DQ, Chua J, Ting D, Schmetterer L, Wong TY, Cheng CY, Tan ACS. Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography. Sci Rep. 06 2020;10(1):9580.
Chua J, Chin CWL, Hong J, Chee ML, Le TT, Ting DSW, Wong TY, Schmetterer L. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography. J Hypertens. 03 2019;37(3):572–580.
Sedaghat S, Vernooij MW, Loehrer E, Mattace-Raso FU, Hofman A, van der Lugt A, Franco OH, Dehghan A, Ikram MA. Kidney function and cerebral blood flow: the Rotterdam study. J Am Soc Nephrol. 2016;27(3):715–21.
Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39(1):55–61.
Zhuang X, Cao D, Zeng Y, Yang D, Yao J, Kuang J, Xie J, He M, Cai D, Zhang S, Wang W, Zhang L. Associations between retinal microvasculature/microstructure and renal function in type 2 diabetes patients with early chronic kidney disease. Diabetes Res Clin Pract. 2020 Oct;168:108373.
Mohandas R, Segal M, Srinivas TR, Johnson BD, Wen X, Handberg EM, Petersen JW, Sopko G, Merz CN, Pepine CJ. Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J. 2015;169(3):412–8.
Mohandas R, Segal MS, Huo T, Handberg EM, Petersen JW, Johnson BD, Sopko G, Bairey Merz CN, Pepine CJ. Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia. PLoS One. 2015;10(5):e0125374.
Sakamoto N, Iwaya S, Owada T, Nakamura Y, Yamauchi H, Hoshino Y, Mizukami H, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y. A reduction of coronary flow reserve is associated with chronic kidney disease and long-term cardio-cerebrovascular events in patients with non-obstructive coronary artery disease and vasospasm. Fukushima J Med Sci. 2012;58(2):136–43.
Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Bibbo CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 02 2018;93(2):501–509.
Prommer HU, Maurer J, von Websky K, Freise C, Sommer K, Nasser H, Samapati R, Reglin B, Guimarães P, Pries AR, Querfeld U. Chronic kidney disease induces a systemic microangiopathy, tissue hypoxia and dysfunctional angiogenesis. Sci Rep. 2018;8(1):5317. Published 2018 Mar 28.
Castro P, Azevedo E, Rocha I, Sorond F, Serrador JM. Chronic kidney disease and poor outcomes in ischemic stroke: is impaired cerebral autoregulation the missing link? BMC Neurol. 2018;18(1):21.
Balk EM, Karas RH, Jordan HS, Kupelnick B, Chew P, Lau J. Effects of statins on vascular structure and function: a systematic review. Am J Med. 2004;117(10):775–90.
Ludwig S, Shen G. Statins for Diabetic Cardiovascular Complications. Curr Vasc Pharmacol. 2006;4(3):245–51.
Kohno M, Murakawa K, Yasunari K, Yokokawa K, Horio T, Kano H, Minami M, Yoshikawa J. Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients. Metabolism. 1997;46(3):287–91.
Tur E, Politi Y, Rubinstein A. Cutaneous blood flow abnormalities in hypertriglyceridemia. J Invest Dermatol. 1994;103(4):597–600.
Yamada M, Huang Z, Dalkara T, Endres M, Laufs U, Waeber C, Huang PL, Liao JK, Moskowitz MA. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab. 2000;20:709–17.
Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001;32(4):980–6.
Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, Qiu J, Amin-Hanjani S, Huang PL, Liao JK, Lo EH, Moskowitz MA. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25(6):722–9.
Xu G, Fitzgerald ME, Wen Z, Fain SB, Alsop DC, Carroll T, Ries ML, Rowley HA, Sager MA, Asthana S, Johnson SC, Carlsson CM. Atorvastatin therapy is associated with greater and faster cerebral hemodynamic response. Brain Imaging Behav. 2008;2:94.
Sander K, Hof U, Poppert H, Conrad B, Sander D. Improved cerebral vasoreactivity after statin administration in healthy adults. J Neuroimaging. 2005;15:266–70.
Forteza A, Romano JG, Campo-Bustillo I, Campo N, Haussen DC, Gutierrez J, Koch S. High-dose atorvastatin enhances impaired cerebral vasomotor reactivity. J Stroke Cerebrovasc Dis. 2012;21:487–92.
Freitas F, Estato V, Reis P, Castro-Faria-Neto HC, Carvalho V, Torres R, Lessa MA, Tibirica E. Acute simvastatin treatment restores cerebral functional capillary density and attenuates angiotensin II-induced microcirculatory changes in a model of primary hypertension. Microcirculation. 2017 Nov;24(8).
Haak E, Abletshauser C, Weber S, Goedicke C, Martin N, Hermanns N, Lackner K, Kusterer K, Usadel KH, Haak T. Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atherosclerosis. 2001;155(2):395–401.
Joris PJ, Mensink RP, Adam TC, Liu TT. Cerebral blood flow measurements in adults: a review on the effects of dietary factors and exercise. Nutrients. 2018;10(5):530. Published 2018 Apr 25.
Purkayastha S, Sorond F. Transcranial Doppler ultrasound: technique and application. Semin Neurol. 2012;32(4):411–20.
Proisy M, Mitra S, Uria-Avellana C, Sokolska M, Robertson NJ, Le Jeune F, Ferré JC. Brain perfusion imaging in neonates: an overview. AJNR Am J Neuroradiol. 2016;37(10):1766–73.
Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. Aug 2012;18(8):RA138–144.
Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerve - a review. Clin Exp Ophthalmol. 2009;37(1):90–9.
Havelius U, Bergqvist D, Falke P, Hindfelt B, Krakau TI. Impaired dark adaptation in symptomatic carotid artery disease. Neurology. 1997;49(5):1353–9.
Kofoed PK, Munch IC, Holfort SK, Sillesen H, Jensen LP, Iversen HK, Larsen M. Cone pathway function in relation to asymmetric carotid artery stenosis: correlation to blood pressure. Acta Ophthalmol. 2013;91(8):728–32.
Sayin N, Kara N, Uzun F, Akturk IF. A quantitative evaluation of the posterior segment of the eye using spectral-domain optical coherence tomography in carotid artery stenosis: a pilot study. Ophthalmic Surg Lasers Imaging Retina. 2015;46(2):180–5.
Wang D, Li Y, Zhou Y, Jin C, Zhao Q, Wang A, Wu S, Wei WB, Zhao X, Jonas JB. Asymptomatic carotid artery stenosis and retinal nerve fiber layer thickness. A community-based, observational study. PLoS One. 2017;12(5):e0177277.
Çakır A, Düzgün E, Demir S, Çakır Y, Ünal MH. Spectral domain optical coherence tomography findings in carotid artery disease. Turk J Ophthalmol. 2017;47(6):326–30.
Heßler H, Zimmermann H, Oberwahrenbrock T, Kadas EM, Mikolajczak J, Brandt AU, Kauert A, Paul F, Schreiber SJ. No evidence for retinal damage evolving from reduced retinal blood flow in carotid artery disease. Biomed Res Int. 2015;2015:604028.
Yan J, Yang X, Wu J, Liu B, Jiao X, Li W, Guo M. Visual outcome of carotid endarterectomy in patients with carotid artery stenosis. Ann Vasc Surg. 2019;58:347–56.
Guclu O, Guclu H, Huseyin S, Korkmaz S, Yuksel V, Canbaz S, Pelitli GV. Retinal ganglion cell complex and peripapillary retinal nerve fiber layer thicknesses following carotid endarterectomy. Int Ophthalmol. 2019;39(7):1523–31.
Akca Bayar S, Kayaarası Öztürker Z, Pınarcı EY, Ercan ZE, Akay HT, Yılmaz G. Structural analysis of the retina and choroid before and after carotid artery surgery. Curr Eye Res. 04 2020;45(4):496–503.
Funding
Open access funding provided by Semmelweis University. This study was supported by the Government of Hungary (EFOP-3.6.3-VEKOP-16–2017–00009).
Author information
Authors and Affiliations
Contributions
IK, LI—conception and design of the work; IK, LI, FB, and AE—acquisition of data; IK and LI—analysis and interpretation of data; IK, LI, ZsM, SP, AV, and ZZsN—conceptualization of the manuscript and review and synthesis of the literature. All authors critically reviewed and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
István, L., Czakó, C., Benyó, F. et al. The effect of systemic factors on retinal blood flow in patients with carotid stenosis: an optical coherence tomography angiography study. GeroScience 44, 389–401 (2022). https://doi.org/10.1007/s11357-021-00492-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-021-00492-1